These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23540266)

  • 41. Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases.
    Gatson JW; Stebbins C; Mathews D; Harris TS; Madden C; Batjer H; Diaz-Arrastia R; Minei JP
    J Neurosurg; 2016 Jun; 124(6):1646-53. PubMed ID: 26613169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunological markers of severity and outcome of traumatic brain injury].
    Ngankam L; Kazantseva NV; Gerasimova MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(7):61-5. PubMed ID: 21947074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.
    Yan EB; Satgunaseelan L; Paul E; Bye N; Nguyen P; Agyapomaa D; Kossmann T; Rosenfeld JV; Morganti-Kossmann MC
    J Neurotrauma; 2014 Apr; 31(7):618-29. PubMed ID: 24279428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients.
    Kaneda K; Fujita M; Yamashita S; Kaneko T; Kawamura Y; Izumi T; Tsuruta R; Kasaoka S; Maekawa T
    Brain Res Bull; 2010 Jan; 81(1):173-7. PubMed ID: 19887101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy.
    Narotam PK; Morrison JF; Nathoo N
    J Neurosurg; 2009 Oct; 111(4):672-82. PubMed ID: 19463048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article.
    Adamczak S; Dale G; de Rivero Vaccari JP; Bullock MR; Dietrich WD; Keane RW
    J Neurosurg; 2012 Dec; 117(6):1119-25. PubMed ID: 23061392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
    Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
    J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury.
    Marklund N; Blennow K; Zetterberg H; Ronne-Engström E; Enblad P; Hillered L
    J Neurosurg; 2009 Jun; 110(6):1227-37. PubMed ID: 19216653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury.
    Zhang ZY; Zhang LX; Dong XQ; Yu WH; Du Q; Yang DB; Shen YF; Wang H; Zhu Q; Che ZH; Liu QJ; Jiang L; Du YF
    Peptides; 2014 Oct; 60():13-7. PubMed ID: 25076464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    Kasai T; Kondo M; Ishii R; Tanaka A; Ataka S; Shimada H; Tomiyama T; Mori H; Taylor M; Allsop D; Nakagawa M; Mizuno T; Tokuda T
    PLoS One; 2017; 12(4):e0174630. PubMed ID: 28394917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
    Mondello S; Robicsek SA; Gabrielli A; Brophy GM; Papa L; Tepas J; Robertson C; Buki A; Scharf D; Jixiang M; Akinyi L; Muller U; Wang KK; Hayes RL
    J Neurotrauma; 2010 Jul; 27(7):1203-13. PubMed ID: 20408766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
    Shahim P; Rejdak R; Ksiazek P; Blennow K; Zetterberg H; Mattsson N; Rejdak K
    Eur J Neurol; 2014 Mar; 21(3):486-91. PubMed ID: 24372994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
    J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
    Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson EJ; Nicoll JA
    J Neurotrauma; 2003 Mar; 20(3):243-50. PubMed ID: 12820678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring of β-amyloid dynamics after human traumatic brain injury.
    Marklund N; Farrokhnia N; Hånell A; Vanmechelen E; Enblad P; Zetterberg H; Blennow K; Hillered L
    J Neurotrauma; 2014 Jan; 31(1):42-55. PubMed ID: 23829439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum.
    Fraser DD; Close TE; Rose KL; Ward R; Mehl M; Farrell C; Lacroix J; Creery D; Kesselman M; Stanimirovic D; Hutchison JS;
    Pediatr Crit Care Med; 2011 May; 12(3):319-24. PubMed ID: 20625342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.
    Beers SR; Berger RP; Adelson PD
    J Neurotrauma; 2007 Jan; 24(1):97-105. PubMed ID: 17263673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury.
    Phillips DJ; Nguyen P; Adamides AA; Bye N; Rosenfeld JV; Kossmann T; Vallance S; Murray L; Morganti-Kossmann MC
    J Neurotrauma; 2006 Sep; 23(9):1283-94. PubMed ID: 16958581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-amyloid oligomer.
    Yu CW; Chen KT; Liu YL; Hsieh YC; Huang DW; Lee YF; Chien TJ; Hueng DY
    J Neurosurg; 2013 Nov; 119(5):1352. PubMed ID: 23952920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.